Aurora kinase inhibitor TC-A-2317 HCl, Purity ≥98%

Cat. No.: X23-10-ZQ487

Aurora kinase inhibitor TC-A-2317 HCl, Purity ≥98%

Synonym: TC-A 2317 hydrochloride; 1245907-03-2; TC-A2317 HCl; TC-A 2317 (hydrochloride); 2-[(5-Hydroxy-1,5-dimethylhexyl)amino]-4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-3-pyridinecarbonitrile hydrochloride; CHEMBL1778662; 2-[(5-Hydroxy-1,5-dimethylhexyl)amino]-4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-3-pyridinecarbonitrilehydrochloride; Aurora kinase inhibitor

  • CAS Number: 1245907-03-2
  • Compound CID: 46911725
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
TC-A-2317 HCl is an Aurora kinase inhibitor that disrupts cell division processes.
Molecular Weight
392.93
Molecular Formula
C19H28N6O.HCl
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
TC-A-2317 HCl can be used in cancer research to study the effects of selective inhibition of Aurora B kinase.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.